Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.
FlashNews:
From Hunger and the Iron Curtain to Page and Plot: Author Angelo Amabile Releases a Gripping Thriller and a Powerful Memoir
Merrill Lynch HNWX High-Net-Worth Accounts: Helping Complex Family Wealth Transition from Embedded Structures to Professional Management
National Lampoon Partners With Producer Rip Micheals and 5120 Entertainment to Launch a New Era of Comedy
Camtep Continues Development of Cross-Border Business Collaboration Platform
How European Money Is Changing Beauty’s Deal Flow
FATF targets crypto hubs in review of money laundering controls
Alstom shares tumble 28% after train maker cuts profit forecast
How Putin has split the west
Binance hackers begin swapping stolen Solana tokens for Bitcoin: Chainalysis
Buying an Outdoor TV: What IP Ratings and Weatherproof Claims Do—and Do Not—Tell You
Rapide Group (OTC: RAPI) Signs Letter of Intent to Acquire Indonesian Commodities Business
Outlander celebrated with special Bafta Scotland award
When You Should—and Shouldn’t—Use AI to Search the Web
18 Best Gifts for PC Gamers (2026): Headsets, Desks, Monitors
BacBit Inc. Unveils Next-Generation AI-Driven Digital Asset Trading Ecosystem
Estée Lauder Raises Outlook, Buoyed by Perfume Demand
St. Vincent and the Grenadines unveils new tourism brand identity
A321neo flies employees’ stories across Europe
From a life-changing garlic press to a super-glowy serum: 12 buys you’re loving right now
Home » Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute